Live Breaking News & Updates on Johnson Innovative

Stay updated with breaking news from Johnson innovative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TAR-210 results show 90 percent recurrence-free survival

Updated results reinforce the potential of TAR-210 to transform treatment of non-muscle-invasive bladder cancer with fibroblast growth factor receptor. ....

Barcelona , Comunidad-autonoma-de-cataluna , Spain , Beerse , Region-flamande , Belgium , San-antonio , Texas , United-states , Vilaseca , American , Europ-urol

Phase 2 data for ERLEADA® ▼(apalutamide) plus androgen

Study highlights opportunity for treatment intensification in this population since approximately 50 percent of patients with high-risk localised prostate. ....

Texas , United-states , Belgium , Beerse , Region-flamande , San-antonio , American , Henar-hevia , Luca-dezzani , Exchange-commission , Janssen-research-development , Johnson

J&J: to present advances in retinal diseases

Johnson & Johnson announces that it will sponsor eight data presentations at the 2024 annual meeting of the Association for Research in Vision and Ophthalmology , to be held in Seattle from May 5 to. ....

Hideo-makimura , Association-for-research , Johnson , Vice-president , Global-head , Johnson-innovative , Markets ,

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer

/PRNewswire/ Johnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study evaluating the efficacy and safety of. ....

United-kingdom , United-states , Texas , San-antonio , American , Ania-diantonio , Indianj-urol , Joseph-jacob , Prnewswire-johnson , Clin-urol , Janssen-research-development , American-cancer-society

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer
bubblear.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bubblear.com Daily Mail and Mail on Sunday newspapers.

San-antonio , Texas , United-states , United-kingdom , American , Joseph-jacob , Clin-urol , Indianj-urol , Ania-diantonio , Department-of-urology , European-association-of-urology , European-society-for-medical-oncology